A new market research report on the Global Transcatheter Aortic Valve Implantation market has introduced by KD Market Insights. The report is dedicated to in-depth industry analysis of the global Transcatheter Aortic Valve Implantation market. The Global Transcatheter Aortic Valve Implantation analysis is broken down on different segmentation levels including Market By Procedure.
The transcatheter aortic valve implantation (TAVI) market revenue was valued at $2,761 million in 2017 and is expected to reach $8,138 million by 2025, growing at a CAGR of 13.8% from 2018 to 2025. The volume market was valued at 107,011 units in 2017 and is expected to reach 337,778 units by 2025, growing at a CAGR of 14.8% from 2018 to 2025.
Get Report Sample Copy @ https://www.kdmarketinsights.com/sample/4126
Transcatheter aortic valve implantation, also called as transcatheter aortic valve replacement, is a minimally invasive surgical procedure, which is performed to treat high-risk patients suffering from aortic stenosis. These high-risk patients refer to the patient population who cannot undergo surgical aortic valve replacement (SAVR) procedure. Older population (above 75 years of age) falls under the high-risk category, as the open-heart procedure is too risky for them. TAVR involves implantation of transcatheter aortic valves to regenerate the blood circulation ability of the aortic valve. The need of transcatheter aortic valve implantation is on the rise due to the increase in prevalence of aortic stenosis.
TAVI experiences market growth due to rise in geriatric population. Furthermore, advancements in the transcatheter aortic valves and increase in adoption rate of TAVI devices drive the market. However, stringent government regulations for approval of transcatheter aortic valves, which are class III medical devices and high cost associated with TAVI hamper the market growth. Conversely, use of TAVI systems for new indications, rise in healthcare expenditure in emerging economies, and increase in the interest of key players in the TAVI market are projected to provide several growth opportunities for the market throughout the forecast period.
The report segments the TAVI market based on procedure and region. According to procedure, it is classified into transfemoral implantation, transapical implantation, and transaortic implantation. Based on region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, Switzerland, UK, and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), and LAMEA (Brazil, Israel, South Africa, Saudi Arabia, and Rest of LAMEA).
KEY BENEFITS
- This report provides an extensive analysis of the current and emerging market trends, and dynamics in the global TAVI market.
- An in-depth analysis is conducted by constructing market estimations for the key segments between 2017 and 2025.
- This report entails the detailed quantitative analysis of the current trends and future estimations through 2017-2025, which assists to identify the prevailing opportunities.
- Comprehensive analysis of factors that drive and restrict the growth of the TAVI market is provided.
- An in-depth analysis of the current research and clinical developments within the TAVI market is provided.
- Key players are profiled, and their strategies are analyzed thoroughly, which interprets the competitive outlook of the market.
KEY MARKET SEGMENTS
By Procedure
- Transfemoral Implantation
- Transapical Implantation
- Transaortic Implantation
By Region
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- Italy
- Switzerland
- UK
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
LAMEA
- Brazil
- Israel
- South Africa
- Saudi Arabia
- Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
- Abbott Laboratories
- Boston Scientific Corporation (Symetis SA)
- Bracco S.p.A. (HLT, Inc.)
- Edwards Lifesciences Corporation
- JenaValve Technology, Inc.
- JC Medical, Inc.
- Medtronic plc
- Meril Life Sciences Pvt. Ltd.
- NVT AG
- Venus Medtech, Inc.
Access Complete Research Report with TOC @ https://www.kdmarketinsights.com/product/transcatheter-aortic-valve-implantation-market-amr
Table of Content
CHAPTER 1: INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. KEY PLAYERS
1.5. RESEARCH METHODOLOGY
1.5.1. Secondary research
1.5.2. Primary research
1.5.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3: MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of new entrants
3.3.4. Intensity of rivalry
3.3.5. Threat of substitutes
3.4. MARKET SHARE ANALYSIS, 2017
3.5. GOVERNMENT REGULATIONS
3.5.1. U.S. FDA
3.5.2. Europe CE Mark
3.5.3. Ministry of Health, Labour and Welfare (MHLW)
3.6. CLINICAL TRIALS
3.7. MARKET DYNAMICS
3.7.1. Drivers
3.7.1.1. Rise in prevalence of aortic stenosis coupled with increase in geriatric population
3.7.1.2. Increase in adoption rate for transcatheter aortic valve implantation procedure
3.7.1.3. Increase in clinical evidence of safety and efficacy and new device approvals
3.7.1.4. Increase in number of TAVR Centers
3.7.2. Restraints
3.7.2.1. High cost of the device and unfavorable reimbursement policies
3.7.2.2. Stringent regulatory approval process
3.7.3. Opportunities
3.7.3.1. Use of TAVI systems for new indications
3.7.3.2. Rise in healthcare expenditure of developing countries
3.7.3.3. Increase in interest of local to global players in the TAVI market
3.7.4. Impact Analyses
CHAPTER 4: TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, BY PROCEDURE
4.1. OVERVIEW
4.1.1. Key market trends, growth factors, and opportunities
4.1.2. Market size and forecast
4.1.3. Market volume and forecast
4.2. TRANSFEMORAL (TF) IMPLANTATION
4.2.1. Market size and forecast
4.2.2. Market volume and forecast
4.3. TRANSAPICAL (TA) IMPLANTATION
4.3.1. Market size and forecast
4.3.2. Market volume and forecast
4.4. TRANSAORTIC IMPLANTATION
4.4.1. Market size and forecast
4.4.2. Market volume and forecast
CHAPTER 5: TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, BY REGION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.1.2. Market volume and forecast
5.2. NORTH AMERICA
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by country
5.2.3. Market volume and forecast, by country
5.2.3.1. U.S.
5.2.3.2. Canada
5.2.3.3. Mexico
5.2.4. Market size and forecast, by procedure
5.2.5. Market volume and forecast, by procedure
5.3. EUROPE
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by country
5.3.3. Market volume and forecast, by country
5.3.3.1. Germany
5.3.3.2. France
5.3.3.3. Italy
5.3.3.4. Switzerland
5.3.3.5. UK
5.3.3.6. Rest of Europe
5.3.4. Market size and forecast, by procedure
5.3.5. Market volume and forecast, by procedure
5.4. ASIA-PACIFIC
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by country
5.4.3. Market volume and forecast, by country
5.4.3.1. Japan
5.4.3.2. China
5.4.3.3. India
5.4.3.4. Rest of Asia-Pacific
5.4.4. Market size and forecast, by procedure
5.4.5. Market volume and forecast, by procedure
5.5. LAMEA
5.5.1. Key market trends, growth factors, and opportunities
5.5.2. Market size and forecast, by country
5.5.3. Market volume and forecast, by country
5.5.3.1. Brazil
5.5.3.2. South Africa
5.5.3.3. Israel
5.5.3.4. Saudi Arabia
5.5.3.5. Rest of LAMEA
5.5.4. Market size and forecast, by procedure
5.5.5. Market volume and forecast, by procedure
Continue @...
Check for Discount @ https://www.kdmarketinsights.com/discount/4126
About Us:
KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: http://www.kdmarketinsights.com
Read More:
https://pr-wire.blogspot.com/
https://dailyprpost.blogspot.com/
The transcatheter aortic valve implantation (TAVI) market revenue was valued at $2,761 million in 2017 and is expected to reach $8,138 million by 2025, growing at a CAGR of 13.8% from 2018 to 2025. The volume market was valued at 107,011 units in 2017 and is expected to reach 337,778 units by 2025, growing at a CAGR of 14.8% from 2018 to 2025.
Get Report Sample Copy @ https://www.kdmarketinsights.com/sample/4126
Transcatheter aortic valve implantation, also called as transcatheter aortic valve replacement, is a minimally invasive surgical procedure, which is performed to treat high-risk patients suffering from aortic stenosis. These high-risk patients refer to the patient population who cannot undergo surgical aortic valve replacement (SAVR) procedure. Older population (above 75 years of age) falls under the high-risk category, as the open-heart procedure is too risky for them. TAVR involves implantation of transcatheter aortic valves to regenerate the blood circulation ability of the aortic valve. The need of transcatheter aortic valve implantation is on the rise due to the increase in prevalence of aortic stenosis.
TAVI experiences market growth due to rise in geriatric population. Furthermore, advancements in the transcatheter aortic valves and increase in adoption rate of TAVI devices drive the market. However, stringent government regulations for approval of transcatheter aortic valves, which are class III medical devices and high cost associated with TAVI hamper the market growth. Conversely, use of TAVI systems for new indications, rise in healthcare expenditure in emerging economies, and increase in the interest of key players in the TAVI market are projected to provide several growth opportunities for the market throughout the forecast period.
The report segments the TAVI market based on procedure and region. According to procedure, it is classified into transfemoral implantation, transapical implantation, and transaortic implantation. Based on region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, Switzerland, UK, and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), and LAMEA (Brazil, Israel, South Africa, Saudi Arabia, and Rest of LAMEA).
KEY BENEFITS
- This report provides an extensive analysis of the current and emerging market trends, and dynamics in the global TAVI market.
- An in-depth analysis is conducted by constructing market estimations for the key segments between 2017 and 2025.
- This report entails the detailed quantitative analysis of the current trends and future estimations through 2017-2025, which assists to identify the prevailing opportunities.
- Comprehensive analysis of factors that drive and restrict the growth of the TAVI market is provided.
- An in-depth analysis of the current research and clinical developments within the TAVI market is provided.
- Key players are profiled, and their strategies are analyzed thoroughly, which interprets the competitive outlook of the market.
KEY MARKET SEGMENTS
By Procedure
- Transfemoral Implantation
- Transapical Implantation
- Transaortic Implantation
By Region
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- Italy
- Switzerland
- UK
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
LAMEA
- Brazil
- Israel
- South Africa
- Saudi Arabia
- Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
- Abbott Laboratories
- Boston Scientific Corporation (Symetis SA)
- Bracco S.p.A. (HLT, Inc.)
- Edwards Lifesciences Corporation
- JenaValve Technology, Inc.
- JC Medical, Inc.
- Medtronic plc
- Meril Life Sciences Pvt. Ltd.
- NVT AG
- Venus Medtech, Inc.
Access Complete Research Report with TOC @ https://www.kdmarketinsights.com/product/transcatheter-aortic-valve-implantation-market-amr
Table of Content
CHAPTER 1: INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. KEY PLAYERS
1.5. RESEARCH METHODOLOGY
1.5.1. Secondary research
1.5.2. Primary research
1.5.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3: MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of new entrants
3.3.4. Intensity of rivalry
3.3.5. Threat of substitutes
3.4. MARKET SHARE ANALYSIS, 2017
3.5. GOVERNMENT REGULATIONS
3.5.1. U.S. FDA
3.5.2. Europe CE Mark
3.5.3. Ministry of Health, Labour and Welfare (MHLW)
3.6. CLINICAL TRIALS
3.7. MARKET DYNAMICS
3.7.1. Drivers
3.7.1.1. Rise in prevalence of aortic stenosis coupled with increase in geriatric population
3.7.1.2. Increase in adoption rate for transcatheter aortic valve implantation procedure
3.7.1.3. Increase in clinical evidence of safety and efficacy and new device approvals
3.7.1.4. Increase in number of TAVR Centers
3.7.2. Restraints
3.7.2.1. High cost of the device and unfavorable reimbursement policies
3.7.2.2. Stringent regulatory approval process
3.7.3. Opportunities
3.7.3.1. Use of TAVI systems for new indications
3.7.3.2. Rise in healthcare expenditure of developing countries
3.7.3.3. Increase in interest of local to global players in the TAVI market
3.7.4. Impact Analyses
CHAPTER 4: TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, BY PROCEDURE
4.1. OVERVIEW
4.1.1. Key market trends, growth factors, and opportunities
4.1.2. Market size and forecast
4.1.3. Market volume and forecast
4.2. TRANSFEMORAL (TF) IMPLANTATION
4.2.1. Market size and forecast
4.2.2. Market volume and forecast
4.3. TRANSAPICAL (TA) IMPLANTATION
4.3.1. Market size and forecast
4.3.2. Market volume and forecast
4.4. TRANSAORTIC IMPLANTATION
4.4.1. Market size and forecast
4.4.2. Market volume and forecast
CHAPTER 5: TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, BY REGION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.1.2. Market volume and forecast
5.2. NORTH AMERICA
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by country
5.2.3. Market volume and forecast, by country
5.2.3.1. U.S.
5.2.3.2. Canada
5.2.3.3. Mexico
5.2.4. Market size and forecast, by procedure
5.2.5. Market volume and forecast, by procedure
5.3. EUROPE
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by country
5.3.3. Market volume and forecast, by country
5.3.3.1. Germany
5.3.3.2. France
5.3.3.3. Italy
5.3.3.4. Switzerland
5.3.3.5. UK
5.3.3.6. Rest of Europe
5.3.4. Market size and forecast, by procedure
5.3.5. Market volume and forecast, by procedure
5.4. ASIA-PACIFIC
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by country
5.4.3. Market volume and forecast, by country
5.4.3.1. Japan
5.4.3.2. China
5.4.3.3. India
5.4.3.4. Rest of Asia-Pacific
5.4.4. Market size and forecast, by procedure
5.4.5. Market volume and forecast, by procedure
5.5. LAMEA
5.5.1. Key market trends, growth factors, and opportunities
5.5.2. Market size and forecast, by country
5.5.3. Market volume and forecast, by country
5.5.3.1. Brazil
5.5.3.2. South Africa
5.5.3.3. Israel
5.5.3.4. Saudi Arabia
5.5.3.5. Rest of LAMEA
5.5.4. Market size and forecast, by procedure
5.5.5. Market volume and forecast, by procedure
Continue @...
Check for Discount @ https://www.kdmarketinsights.com/discount/4126
About Us:
KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: http://www.kdmarketinsights.com
Read More:
https://pr-wire.blogspot.com/
https://dailyprpost.blogspot.com/
No comments:
Post a Comment